BC
AGN

Brinker Capital’s Allergan plc AGN Stock Holding History

Brinker Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-3,571
Closed -$477K – 976
2018
Q4 		$477K Sell
3,571
-705
-16% -$116K 0.02% 614
2018
Q3 		$815K Buy
4,276
+834
+24% +$153K 0.03% 555
2018
Q2 		$574K Sell
3,442
-736
-18% -$118K 0.02% 659
2018
Q1 		$703K Buy
4,178
+738
+21% +$124K 0.03% 594
2017
Q4 		$563K Sell
3,440
-16,091
-82% -$2.89M 0.02% 651
2017
Q3 		$4M Sell
19,531
-376
-2% -$87.4K 0.17% 134
2017
Q2 		$4.84M Buy
19,907
+2,028
+11% +$477K 0.22% 106
2017
Q1 		$4.27M Buy
17,879
+3,900
+28% +$908K 0.2% 110
2016
Q4 		$2.94M Buy
+13,979
New +$2.9M 0.16% 137
2015
Q3 		– Sell
-23,663
Closed -$7.18M – 147
2015
Q2 		$7.18M Buy
+23,663
New +$7.06M 0.6% 36

Other funds holding AGN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $6.16B AUM 3.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Brinker Capital's AGN Position: Q1 2019 in Review

Brinker Capital sold out of Allergan plc (AGN) in Q1 2019, closing a stake of 3,571 shares — an estimated $477K sold.

Brinker Capital first reported a position in AGN in Q2 2015 and held it in 10 quarters. The position peaked at $7.18M in Q2 2015. 991 funds tracked by Wall St. Rank hold AGN as of Q1 2019.

  • Brinker Capital reported no remaining Allergan plc position as of Q1 2019 after selling out during the quarter.
  • Brinker Capital sold 3,571 Allergan plc shares in Q1 2019, an estimated $477K.
  • Brinker Capital first reported a position in Allergan plc in Q2 2015 and held it in 10 quarters.
  • Brinker Capital's Allergan plc position peaked at $7.18M in Q2 2015.
  • 991 funds tracked by Wall St. Rank held Allergan plc as of Q1 2019.

Based on Brinker Capital's 13F filing for Q1 2019, filed 23 Apr 2019.